Entera Bio Ltd
For the period ended Dec 31, 2023. Filed Mar 8, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 8, 2024
ENTX$3.24-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
| Item 8. | FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA |
|---|
CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
TABLE OF CONTENTS
| Page | |
|---|---|
| REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID 1309) | 87 |
| CONSOLIDATED FINANCIAL STATEMENTS: | |
| Consolidated Balance Sheets | 88 |
| Consolidated Statements of Operations | 89 |
| Consolidated Statements of Changes in Shareholders' Equity | 90 |
| Consolidated Statements of Cash Flows | 91 |
| Notes to the Consolidated Financial Statements | 92 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.